Malignant Phyllodes Tumor of Prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Neoplasm Recurrence, Local
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
39
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Prostatic Adenoma
|
disease |
Male Urogenital Diseases
|
Neoplastic Process
|
8
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Benign prostatic hypertrophy
|
phenotype |
Male Urogenital Diseases
|
Pathologic Function
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Disease Exacerbation
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
166
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Recurrent urinary tract infection
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Infections; Male Urogenital Diseases
|
Disease or Syndrome
|
237
|
21
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Psoriasis vulgaris
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
255
|
80
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Chronic Periodontitis
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
287
|
99
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Stage I Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adult Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
405
|
30
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Recurrent Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Systemic Inflammatory Response Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
185
|
9
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Neoplasm, Residual
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
329
|
23
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Residual Cancer
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Drug usage
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
21
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Erectile dysfunction
|
disease |
Male Urogenital Diseases; Mental Disorders
|
Disease or Syndrome
|
256
|
44
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Prostatic pain
|
disease |
Pathological Conditions, Signs and Symptoms; Male Urogenital Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant Head and Neck Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
767
|
118
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Transitional cell carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
333
|
158
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Sleep Apnea, Obstructive
|
disease |
Respiratory Tract Diseases; Nervous System Diseases
|
Disease or Syndrome
|
480
|
105
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lupus Erythematosus
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
558
|
44
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Non-alcoholic Fatty Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1058
|
222
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Nephrolithiasis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
242
|
99
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |